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Abstract
Cervical cancer is the second most common cancer in women worldwide with 80% of cases
arising in the developing world. The mortality associated with cervical cancer can be reduced if
this disease is detected at the early stages of development or at the pre-malignant state (cervical
intra-epithelial neoplasia, CIN). The aim of this study was to investigate the potential of Raman
spectroscopy as a diagnostic tool to detect biochemical changes accompanying cervical cancer
progression. Raman spectra were acquired from proteins, nucleic acids, lipids and carbohydrates
in order to gain an insight into the biochemical composition of cells and tissues. Spectra were
also obtained from histological samples of normal, CIN and invasive carcinoma tissue from 40
patients. Multivariate analysis of the spectra was carried out to develop a classification model to
discriminate normal from abnormal tissue. The results show that Raman spectroscopy displays a
high sensitivity to biochemical changes in tissue during disease progression resulting in an
exceptional prediction accuracy when discriminating between normal cervical tissue, invasive
carcinoma and cervical intra-epithelial neoplasia (CIN). Raman spectroscopy shows enormous
clinical potential as a rapid non invasive diagnostic tool for cervical and other cancers.

Keywords
Vibrational spectroscopy, Raman spectroscopy, cervical cancer, diagnosis, biological
macromolecules, cervical intraepithelial neoplasia (CIN), principal component analysis, linear
discriminant analysis
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Introduction
Cervical cancer is the second most common cancer among women worldwide and generally is
more common in developing countries.

However, substantial decreases in cervical cancer

mortality have been observed in Western countries and some developing countries with well
developed screening programmes (Parkin et al 2005). A Pap smear is used to screen for CIN and
cervical cancer in the general female population. Cervical cytology can have a high specificity
of 95-98% but a sensitivity of lower than 50% (Nanda et al 2000). Other methods such as
automated cytology and human papilloma virus (HPV) testing (Willis et al 2005, Bolger et al
2006, Koliopoulos et al 2006) have been introduced to reduce the false negative rates. An
abnormal Pap smear is followed by colposcopic examination, biopsy and histological
confirmation of the clinical diagnosis. This involves the visual examination of histological
sections.

The grading characteristics are quite subjective and pre-malignancy may not be

visually perceptible at all.
Optical technologies such as fluorescence spectroscopy (Chang et al 2005), polarised light
scattering spectroscopy (Gurjar et al 2001), optical coherence tomography (Escobar et al 2004,
Zuluaga et al 2005) and confocal reflectance microscopy (Carlson et al 2005) have emerged in
recent years as promising tools for diagnosis of cervical and other cancers. The potential of
vibrational spectroscopy for cervical cancer diagnosis has also been recognised. A number of
studies have shown that Fourier Transform Infra Red (FTIR) spectroscopy (Wood et al 2003,
Mordechai et al 2004, Romeo et al 2004) or Raman spectroscopy (Mahadevan-Jansen et al 1998,
Utzinger et al 2001, Ó Faoláin et al 2005) can be used for detecting spectral changes in
malignant and pre-malignant cells. Raman spectroscopy is, however, more suited to in vivo
studies because of minimal interference from water.
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Raman spectroscopy is an optical method based on inelastic light scattering. The sample is
illuminated by monochromatic laser light and interactions between the incident photons and
molecules in the sample result in scattering of the light. The exact energy required to excite a
molecular vibration depends on the masses of the atoms involved in the vibration and the type of
chemical bonds between these atoms and may be influenced by molecular structure, molecular
interactions and the chemical microenvironment of the molecule.

Therefore, the positions,

relative intensities and shapes of the bands in a Raman spectrum carry detailed information about
the molecular composition of the sample (Socrates 2004).
The aim of the present study was to gain an insight into the biochemical composition of cells and
tissue by measuring Raman spectra from proteins, nucleic acids, lipids and carbohydrates and to
show the diagnostic potential of Raman spectroscopy for cervical cancer and pre-cancer.
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Materials and methods
Sample preparation
The samples examined were amino acids (all 20 amino acids), a dipeptide (arginine-lysine),
proteins (albumin (bovine), β-galactosidase, and collagen (calf skin)), purines (adenine and
guanine) and pyrimidines (cytosine and thymine), nucleic acid (salmon DNA), carbohydrates
(glucose, glycogen), lipids (phosphatidylcholine and phosphatidylinositol) (Sigma-Aldrich,
Dublin, Ireland). Spectra were recorded in a polycrystalline form on a glass slide with no
preparation required.
Formalin fixed paraffin preserved (FFPP) tissue samples were obtained from both the School of
Biological Sciences, DIT, Kevin Street (tonsil, kidney and prostate) and the National Maternity
Hospital, Holles St., Dublin (cervical tissue). Two parallel 10µm FFPP sections were cut from
each block using a microtome, mounted on glass slides and dried. Samples (with the exception of
cervical tissue) were dewaxed in-house in DIT prior to investigation by immersion in baths of
Xylene (BDH), Ethanol Absolut (Merck) and Industrial Methylated Spirits 95% (Lennox) and
air-dried. Cervical tissue was dewaxed using the same procedure outlined above, but xylene was
substituted with hexane, due to the improved level of dewaxing (Ó Faoláin et al. 2005). One
section from each sample (the reference section) was stained with Haematoxylin and Eosin and
the other kept unstained for spectroscopic examination.

FFPP cervical tissue sections were characterised by consultant pathologist Dr. P. Kelehan,
National Maternity Hospital, Holles St., Dublin, and the samples consisted of 20 normal and 20
invasive carcinoma sections from 40 individuals. Of the 20 carcinoma samples, 10 samples were
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identified as having various grades of cervical intraepithelial neoplasia (CIN), which were also
marked for examination.

Spectroscopy
The Instruments S.A. Labram Raman spectroscopic confocal microscope was used, with an
Argon Ion laser operating at an excitation wavelength of 514.5nm. A x50 objective lens was
used. The laser power at the sample was measured and found to be 6.5±0.05mW, focused to a
spot size of ≈2µm at the tissue surface. A 30 second accumulation time was used for the
crystalline samples. Raman spectra of the various tissues were accumulated for 150 seconds. A
total of 10 spectra were recorded from different spots on each sample.
Selected spectra were baseline corrected, dark current subtracted and were smoothed using a 10
point moving average.

Where multiple spectra are displayed, spectra have been offset to

facilitate clarity.

Data Analysis
All spectra (unfiltered) were subjected to spurious peak (“cosmic ray”) removal and baseline
correction using a common baseline, in Labspec (v. 4.02 Jobin Yvon), before being exported in
ASCII format to Microsoft Excel. Spectra were normalised to the spectral maximum, from 0 to
1. Basic matrix manipulations and data reduction was carried out in Microsoft Excel Professional
2003 (v. 11.0), before being exported into Minitab to perform Principal Component Analysis
(PCA) and Linear Discriminant Analysis (LDA). Minitab Release 14.1 Statistical Software
Analysis Programme was used to produce PCA scores and LDA plots, as well as to carry out
leave-one-out cross validation.
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Results and Discussion

Biochemical Analysis
Amino acids, peptides and proteins
All 20 common amino acids were examined using Raman spectroscopy and found to display
characteristic spectral features. Figure 1a shows the chemical structure and the Raman spectrum
of alanine and phenylalanine. The Raman spectra show many narrow bands, as would be
expected due to the relatively simple structure of the amino acids. Each of the Raman peaks
corresponds to a vibrational energy associated with the bonds within the sample. The most
distinctive peak in the spectrum of phenylalanine is the peak at 1004 cm-1 which can be attributed
to the carbon-carbon stretching mode within the phenyl ring. The fingerprint region of the
spectrum (≈ 500 - 1700 cm-1) contains the majority of information and above 1700 cm-1 the
spectrum contains mainly CH, CH2 and CH3 stretching modes around the 3000 cm-1 region (table
1). The spectra illustrate the ability of Raman spectroscopy to distinguish these molecules with
their own distinctive signature spectrum.
Raman spectra of the amino acids, arginine (Arg) and lysine (Lys) were compared to the Raman
spectrum of the dipeptide Arg-Lys (figure 1b). The spectrum of the dipeptide clearly derives
from a combination of the two amino acids (indicated by the arrows) and interestingly contains a
new peak at 1665 cm-1. This is the Amide I band mainly due to C=O stretching modes of the
peptide bond formed between arginine and lysine (table 1).
Three different proteins, a serum protein, an enzyme and a structural protein, were examined;
albumin, β-galactosidase and collagen (figure 1c). Compared to the amino acids and peptides, it
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is clear that the proteins display a more detailed Raman signature, a function of their structure
and crystalline form.
Purines, pyrimidines and nucleic acids
Figure 2a displays the Raman spectra of the purines and pyrimidines present in DNA, as well as
a spectrum of DNA. Again contributions from the constituent molecules are present in the
spectrum of DNA, but as seen with the protein spectra the peaks broaden as the molecular
complexity increases.
Carbohydrates
Figure 2b shows the Raman spectra of carbohydrates; glucose and glycogen. Glucose displays
many narrow vibrational modes, similar to the spectra of single amino acids, due to its relatively
simple structure. The spectrum of glycogen on the other hand, shows broader spectroscopic
features, as a result of its more complex polysaccharide structure.
Lipids
Raman spectra of phosphatidylcholine and phosphatidylinositol are shown in figure 2c. The two
phospholipids, which exist mainly in the extracellular membrane, can be clearly differentiated by
presence of the peak seen at 714 cm-1, which can be attributed to the C-N vibrational mode in the
membrane phospholipid head (Stone et al 2002) present in phosphatidylcholine but absent in
phosphatidylinositol.
Tissue
Raman spectroscopy has been clearly shown to identify and discriminate between molecular
components of cells and tissue. A number of different tissue types were examined and some of
the generalised assignments common to different tissue types are shown in figure 3. Raman
bands found in these samples include the amide I band, resulting mainly from C=O stretching

8

vibrations of proteins, CH2 bending and CH2 deformation of lipids and carbohydrates, Amide III
vibrations of proteins and CC stretching of carbohydrates.

Diagnostic applications
Cervical cancer
Figure 4 shows the different cell types seen in normal cervical tissue in an unstained FFPP tissue
section together with the Raman spectra recorded from basal cells, epithelial cells and connective
tissue. Spectra were recorded from a single sample and each spectrum represents a different spot
within the sample. The spectra of the three different cell types do have a degree of similarity as
seen previously for different tissue types (figure 3). However, there are also many spectral
features differentiating the different cell types. The spectra of basal cells show strong bands at
724, 779 and 1578 cm-1 which are characteristic of nucleic acids. The same contributions were
observed in the spectrum of DNA (figure 2a). The morphology of basal cells consists of a single
line of tightly packed cells, with large nuclei in relation to the compacted surrounding cytoplasm.
In addition, these cells are constantly dividing, providing cells to the parabasal layer. For both of
these reasons a high concentration of DNA would be expected in the basal cells. Spectra of
epithelial cells have characteristic glycogen bands at 482, 849, 938, 1082 and 1336 cm-1 as
observed in the spectrum of glycogen in figure 2b. Collagen contributions can be clearly seen in
the spectra of connective tissue at 850, 940 and 1245 cm-1 as seen in the spectrum of collagen in
figure 1c.

Figure 5a compares the Raman spectra collected from normal epithelial cells and invasive
carcinoma from a selection of different patients. Glycogen contributions are clearly visible in the
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spectra from the normal epithelial tissue. The most obvious bands arise at 482 cm-1, 849 cm-1 and
938 cm-1 and are due to glycogen skeletal deformation, CCH aromatic deformation and CCH
deformation respectively. However there are also other glycogen contributions not as apparent,
including a CC stretching band at 1082 and CH3CH2 wagging at 1336 cm-1. These glycogen
bands (482, 849 and 938 cm-1) are absent in the spectra from invasive carcinoma, as well as a
reduction in the intensity of the CC stretching mode (1082 cm-1). Glycogen, a polysaccharide, is
the principal storage form of glucose. Cervical cells are unusual among other epithelial cells in
that they accumulate large amounts of glycogen during the maturation process (Chiriboga et al
1998). Glycogen is known to be linked with cellular maturation and disappears with the loss of
differentiation during neoplasia. The spectra of invasive carcinoma also show characteristic
nucleic acid bands. These include prominent bands at 724, 779 and 1578 cm-1, but also at 829,
852, 1002, 1098, 1240 cm-1. Distinct bands were also seen at 1366 cm-1, a shoulder at 1484 cm-1
and a band at 1578 cm-1. An increase in the intensity of the Amide I band (1655cm-1) was
observed in the spectra of carcinoma samples compared to the normal tissue samples. The
increased nucleic acid and protein bands are a result of the increased proliferation of these
tumour cells.
To investigate if pre-malignant changes could be highlighted using Raman spectroscopy, 10
areas of neoplasia (CIN) from 10 different patients were marked by a pathologist and a selection
of the resulting Raman spectra are shown in Figure 5b. A number of the spectral features
identified in the invasive carcinoma samples were also observed in the CIN samples such as the
nucleic acid bands at 724, 779, 852, 1366 and 1578 cm-1. This indicates that early biochemical
changes can be identified using Raman spectroscopy.
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Principal component analysis was used to reduce the number of parameters needed to represent
the variance in the spectral data set. The principal components were then used to generate a
linear discriminant model. PCA is a chemometric technique that can resolve a complete spectral
data set into a few principal components and can thus identify and isolate important trends within
the data set (Jackson 1991). LDA applies a linear discriminant function that maximises the
variance in the data between groups and minimises the variance between members of the same
group (Otto 1999). All three tissue classes were successfully discriminated as shown in figure 6.
The classification model was tested using a leave one out cross validation in which all but one
spectrum was used to build the model. This model was then used to predict the remaining
spectrum. This was repeated for all 498 spectra and the results are shown in table 2. Of 498
tissue spectra, 492 were correctly classified as normal, invasive carcinoma or CIN. The cross
validation mis-classified 6 spectra, 2 of which were normal samples assigned as invasive
carcinoma. The other 4 were either invasive carcinoma or CIN mis-classified as either CIN or
invasive carcinoma respectively. Importantly, no abnormal samples were classified as normal.
Based on the cross validation results, sensitivity and specificity values were calculated as 99.5%
and 100% respectively for normal tissue, 99% and 99.2% respectively for CIN and 98.5% and
99% respectively for invasive carcinoma. It is possible that these values may be slightly over
optimistic because of the LDA method used with leave one out cross validation. However,
similar methods have been used previously to classify bladder and prostate cancer (Crow et al
2005), breast cancer (Haka et al 2002) and basal cell carcinoma (Nijssen et al 2002).

Ideally,

the use of an unknown test set would provide a more robust analysis of the sensitivity and
specificity of the technique and this is planned for future work.
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In conclusion, the results show the ability of Raman spectroscopy to classify cervical cancer and
pre-cancer with high sensitivity and specificity. These classifications are based on biochemical
changes known to accompany cervical cancer such as loss of differentiation and increased
proliferation.

Such an automated technique measuring biochemical changes with improved

diagnostic capability could allow faster, more effective patient management and inevitably
would increase survival rates.

Raman spectroscopy offers enormous potential as a ‘next

generation’ technology to assist pathologists and cytologists with cervical cancer screening and
diagnosis.
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Legends
Figure 1

Raman spectra of (a) alanine (A) and phenylalanine (B), (b) arginine (Arg) (A),
lysine (Lys) (B) and dipeptide Arg-Lys (C) and (c) three proteins in ascending
chain length; albumin (A), β-galactosidase (B) and collagen (C). Assignments of
the main Raman vibrational modes are detailed in table 1.

Figure 2

Raman spectra of a) cytosine (A), thymine (B) (pyrimidines), adenine (C),
guanine (D) (purines) and DNA (E), b) carbohydrates, glucose (A), glycogen (B)
and (c) phospholipids, phosphatidylinositol (A) and phosphatidylcholine (B).
Raman peak assignments are detailed in table 1.

Figure 3

Raman spectral features of various tissues, A) Tonsil B) Kidney and C) Prostate,
with generalised assignments, where ν = stretch and δ = deformation.

Figure 4

(a) Photomicrograph of unstained tissue section, with different cell types
identified and (b) Raman spectra recorded from basal cells (A), epithelial cells (B)
and connective tissue (C) in cervical tissue sections. The main spectral features
associated with each cell type are highlighted.

Figure 5

Raman spectra of a) normal cervical epithelial cells (A) and invasive carcinoma
cells (B) and (b) Raman spectra of CIN tissue. Assignments of the main Raman
vibrational modes are detailed in table 1.

Figure 6

Linear discriminant analysis of the principal components of the first derivative,
normalised, 10 point averaged spectra, over the entire spectral range, C = CIN, N
= normal and T = invasive carcinoma
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Table 1

Table 1

Peak position and assignments of main Raman vibrational modes
Peak Position
(cm-1)
622

Assignment
C-C twisting

724

CH2 deformation

746
754
779
832
853
873
922
1004
1034
1065
1096
1098
1102
1124
1214
1236
1240
1314

CH2 rocking
Symmetric ring breathing
Ring vibration
CCH deformation aliphatic
CCH deformation aromatic
CC stretch
C-C stretching
CC aromatic ring breathing
C-C stretching
C-N stretch
C-C chain stretching
CC stretch
CC stretch
CC skeletal stretch trans
CC stretch backbone carbon phenyl ring
CN stretch, NH bending Amide III band
CN stretch, NH bending Amide III band
CH deformation

1337

CH2 deformation

1335

CH2 deformation

1366

CH2 bending

1440

CH2 scissoring

1484
1548
1578
1585
1602
1660 - 1665

CH2 deformation
NH deformation; CN stretch Amide II band
C=C olefinic stretch
C=C stretching
CO stretching
C=O stretch Amide I α-helix

2930
2932

CH2 stretching (2930 cm-1)
CH3 symmetric stretch (2932 cm-1)

Table 2

Table 2

Summary of cross-validation classification results and sensitivity and

specificity values

Predicted (Raman)
Normal
CIN
Invasive carcinoma

Diagnosis (Histopathology)
Normal
CIN
Invasive carcinoma
198
0
0
0
99
3
2
1
195

Total
Number correct
Proportion

200
198
0.990

100
99
0.990

198
195
0.985

Sensitivity
Specificity

99.5%
100%

99.0%
99.2%

98.5%
99.0%

Figure 1

(a)

(b)

(c)

Figure 2

(a)

(b)

(c)

Figure 3

Figure 4

Figure 5

Figure 6

